1,000+ Opportunities

Find the right grant

Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.

This listing may be outdated. Verify details at the official source before applying.

Find similar grants

ActiveChicago Center on Musculoskeletal Pain (C-COMP) · 2026

Pilot and Feasibility Grants (Chicago Center on Musculoskeletal Pain)

Quick Facts

Agency: Chicago Center on Musculoskeletal Pain (C-COMP)
Funding: See official notice
Deadline: Check Source
Status: Active
Eligibility: New investigators to study pain mechanisms in rheumatic and musculoskeletal diseases, both junior and senior investigators.

About This Grant

Pilot and Feasibility Grants (Chicago Center on Musculoskeletal Pain) is sponsored by Chicago Center on Musculoskeletal Pain (C-COMP). This opportunity supports mission-aligned projects and measurable outcomes.

View Original RFP

Get a weekly digest of new grants like this

A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.

Or search similar grants →

Official Opportunity Details

Extracted from the official opportunity page/RFP to help you evaluate fit faster.

Jul 28, 2023, 3:01 PM ## 2023 Pilot Grant Awardees Announced The Chicago Center on Musculoskeletal Pain would like to announce this year's pilot grant recipients! More… Jun 5, 2024, 2:02 PM ## New Publication | Featured in International Journal of Molecular Sciences- February 1, 2024 Annulus Fibrosus Injury Induces Acute Neuroinflammation and Chronic Glial Response in Dorsal Root Ganglion

and Spinal Cord—An In Vivo Rat Discogenic Pain Model More… Jun 5, 2024, 2:14 PM ## New Publication | Featured in Science Translational Medicine - April 10, 2024 Synovial fibroblast gene expression is associated with sensory nerve growth and pain in rheumatoid arthritis More… Jun 5, 2024, 2:21 PM ## New Publication | Featured in PAIN - May 2024 The

Mas-related G protein–coupled receptor d (Mrgprd) mediates pain hypersensitivity in painful diabetic neuropathy More… Jun 5, 2024, 2:34 PM ## New Publication | Featured in Molecular Pain - May 16, 2024 Reduced Capsaicin-Induced Mechanical Allodynia and Neuronal Responses in the DRG in the Presence of Ptpn6 Overexpression More…

Eligibility Requirements

New investigators to study pain mechanisms in rheumatic and musculoskeletal diseases, both junior and senior investigators.

Frequently Asked Questions

Who can apply for Pilot and Feasibility Grants (Chicago Center on Musculoskeletal Pain)?

According to the current listing, eligibility includes: New investigators to study pain mechanisms in rheumatic and musculoskeletal diseases, both junior and senior investigators. Confirm the full requirements in the official notice before applying.

Who funds Pilot and Feasibility Grants (Chicago Center on Musculoskeletal Pain)?

Pilot and Feasibility Grants (Chicago Center on Musculoskeletal Pain) is funded by Chicago Center on Musculoskeletal Pain (C-COMP). Verify program details on the funder's official page before applying.

How do I apply for Pilot and Feasibility Grants (Chicago Center on Musculoskeletal Pain)?

Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.

Competitive Intelligence

Past winners and funding trends for this program

Full analysis

Funder Profile

Ready to start your proposal?

Granted drafts, reviews, and strengthens your grant application — saving weeks of work. Professional members win a grant in 12 months or get a full refund.

Browse More Grants

Backed by the Granted Guarantee

Chicago Center on Musculoskeletal Pain (C-COMP) Grant Writing Tips

NIH's HEAL Initiative Will Fund Your Non-Opioid Painkiller at Its Riskiest Stage: R61/R33 Analgesic Discovery, $350K a Year, September 17 Deadline

The HEAL Initiative's Studies to Enable Analgesic Discovery award (RFA-NS-25-023) puts federal money exactly where private capital won't go — the assay-building, screening, and hit-characterization stage of non-opioid pain therapeutics. It's a phased R61/R33, up to $350,000 in direct costs per year, with the next application deadline September 17, 2026. Here is how the two-phase structure works, who's eligible, and how to build a proposal that survives the R61-to-R33 milestone gate.

Read article